报告题目：Introduction to Genentech and the State of the Academic/Industrial Interface in the U.S.
报 告 人：Dr. Michael D. Varney
报告时间：2013年5月27日下午3:00
报告地点：苏州大学本部学术报告厅
欢迎广大师生踊跃参加！
Biography
Dr. Michael D. Varney received his B.S. in Chemistry in 1980 from UCLA, and his Ph.D. in synthetic organic chemistry from CalTech in 1985 under the direction of Professor Robert E. Ireland. He was an American Cancer Society postdoctoral fellow at Columbia University where he studied bioorganic chemistry under the direction of Ronald Breslow from 1985-1987. In 1987 he went to Agouron Pharmaceuticals Inc. as a medicinal chemist. In 1997 he was given responsibility for the Research organization as the Corporate Vice President, Head of Research. As part of the acquisition of Warner-Lambert by Pfizer, Mike became the Vice President of Drug Discovery Pfizer Global Research and Development, La Jolla. In 2005 Dr Varney moved to Genentech as the Vice President, Small Molecule Drug Discovery. Dr Varney is now the Senior Vice President, Research and Small Molecule Drug Discovery where he is responsible for all Small Molecule activities as well as the Research portfolio and budget. Dr Varney is also the Co-Chair of the Early Stage Portfolio Committee which is responsible for the management of all aspects of Genentech’s Development portfolio. Dr Varney’s research has focused on the use of combinatorial chemistry and protein structural information in the design of therapeutically relevant drugs in the fields of Viral Diseases, Diabetes, Obesity, Oncology, Ophthalmology, Immunology and Neurodegeneration.
